On the contrary, a recombinant protein of human serum albumin (HSA, 67 kDa) was localized up to three times more in a tumor over time when fused with a tumor targeting agent, amino-terminal fragment (ATF) [45]. The gene discussed is ALB; the disease is neoplasm.